The main cancer therapy targets are tubulin protein, cyclin-dependent kinases (CIKs), epidermal growth factor receptor (EGFR), Ras protein, and, in recent years, cancer stem cells (CSC) [7,8]. This evidence concerns the gene EGFR and cancer.